CHRO
Channel Therapeutics Corporation
AMEXHealthcareBiotechnologyUS
Company Profile
CEO
Francis Knuettel II,
IPO Date
2024-02-16
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Channel Therapeutics Corporation
CEO
Francis Knuettel II,
IPO Date
2024-02-16
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
| 49,605 |
| $0.64 |
| 15 Nov 2024 | Malamut Richard | director | A-Award | Acquired | 24,533 | $0.64 |
| 15 Nov 2024 | Friedberg Ezra M | director | A-Award | Acquired | 24,533 | $0.64 |
| 16 Sept 2024 | Malamut Richard | director | P-Purchase | Acquired | 10,400 | $0.94 |
| 16 Sept 2024 | Francis Knuettel II | CEO, Pres., CFO, Treas & Secty | P-Purchase | Acquired | 3,500 | $0.97 |
| 16 Sept 2024 | Francis Knuettel II | CEO, Pres., CFO, Treas & Secty | P-Purchase | Acquired | 1,700 | $0.97 |
| 12 Sept 2024 | Francis Knuettel II | CEO, Pres., CFO, Treas & Secty | P-Purchase | Acquired | 5,500 | $0.94 |
| 12 Sept 2024 | Francis Knuettel II | CEO, Pres., CFO, Treas & Secty | P-Purchase | Acquired | 6,500 | $0.89 |